Demographic, Environmental, and Genetic Predictors of Metabolic Side Effects of Hydrochlorothiazide Treatment in Hypertensive Subjects
Author(s) -
Anke H. Maitlandvan der Zee,
Stephen T. Turner,
G SCHWARTZ,
A CHAPMAN,
Olaf H. Klungel,
E BOERWINKLE
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.02.012
Subject(s) - hydrochlorothiazide , medicine , dyslipidemia , endocrinology , thiazide , triglyceride , diabetes mellitus , blood pressure , metabolic syndrome , pharmacogenetics , body mass index , genetic variation , cholesterol , population , genotype , biology , genetics , environmental health , gene
Thiazide diuretics are recommended for first-line treatment of hypertension. Although considered safe and effective, their use is associated with dyslipidemia, hyperglycemia, and an increased risk of developing type 2 diabetes. The aim of this study was to characterize interindividual variation in glucose and lipid responses to hydrochlorothiazide and to identify demographic, environmental, and genetic predictors associated with this variation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom